Pancreatic Cancer Research

ResearcherSheng Jing HospitalActive in the last 2 years

Jian Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3596-4339; OpenAlex author ID A5031444445, A5125635123. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. OTUD4 regulates pancreatic cancer progression via Hippo/YAP axis. Co-author DOI 10.1016/j.neo.2026.101285↗
  2. Regulation of the Hippo/YAP signaling pathway in pancreatic cancer by the deubiquitinase POH1 Co-author DOI 10.21203/rs.3.rs-6633989/v1↗
  3. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation. Co-author DOI 10.1080/15384101.2020.1827189↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuaike Qu · 1 shared paper, 2026 · strength 0.27
  2. Xiaodong Tan · 1 shared paper, 2026 · strength 0.27
  3. Wenjing Sun · 1 shared paper, 2025 · strength 0.22
  4. Xiaodong Tan · 1 shared paper, 2025 · strength 0.22
  5. Zhihao Liu · 1 shared paper, 2025 · strength 0.22
  6. Yong Ji · 1 shared paper, 2020 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.